Clinical Trial Update: Retrospective Study Assessing Molecular Features Predicting Response to Cetuximab

View source ↗

Summary

A retrospective study from Istituto Clinico Humanitas investigates molecular features that may predict colorectal cancer response to cetuximab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Colorectal Neoplasms | Status: COMPLETED